Trevi Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 34K | 0 | 0 | 0 | 0 | 38K | 0 | 38K |
| Gross Profit | -34K | 0 | 0 | 0 | 0 | -38K | 0 | -38K |
| R&D Expenses | 9.9M | 6.2M | 10.1M | 9.4M | 7.8M | 9.3M | 11.2M | 10.0M |
| Operating Expenses | 14.9M | 10.2M | 13.9M | 13.7M | 11.5M | 12.2M | 14.1M | 13.3M |
| Operating Income | -14.9M | -10.2M | -13.9M | -13.7M | -11.5M | -12.2M | -14.1M | -13.3M |
| Other Income / Gains | 1.7M | 1.9M | 2.1M | 1.4M | 1.1M | 844K | 814K | 929K |
| Net Income | -13.2M | -8.3M | -11.8M | -12.3M | -10.3M | -11.4M | -13.2M | -12.4M |
| EPS (Diluted) | -0.091 | -0.057 | -0.08 | -0.094 | -0.088 | -0.11 | -0.13 | -0.12 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 5.0M | 4.0M | 3.8M | 4.3M | 3.7M | 0 | 2.9M | 3.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -38K |
| Selling General And Administrative Expenses | 5.0M | 4.0M | 3.8M | 4.3M | 3.7M | 2.9M | 2.9M | 3.2M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 14.9M | 10.2M | 13.9M | 13.7M | 11.5M | 12.2M | 14.1M | 13.3M |
| Interest Income | 1.7M | 1.9M | 2.1M | 1.4M | 1.1M | 843K | 826K | 935K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 1K | 1K | 1K |
| Depreciation And Amortization | 34K | 31K | 38K | 38K | 37K | 38K | 36K | 38K |
| Ebitda | -13.2M | -8.3M | -11.8M | -12.3M | -10.3M | -11.4M | -13.2M | -12.3M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -13.2M | -8.3M | -11.8M | -12.3M | -10.4M | -11.4M | -13.3M | -12.4M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | -20K | -16K | -15K | -21K | -11K | 16K | -31K | -8K |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.091 | -0.057 | -0.08 | -0.094 | -0.088 | -0.11 | -0.13 | -0.12 |
| Weighted Average Shs Out | 145.6M | 145.5M | 145.1M | 130.4M | 117.6M | 106.0M | 101.0M | 101.0M |
| Weighted Average Shs Out Dil | 145.6M | 145.5M | 145.1M | 130.4M | 117.6M | 106.0M | 101.0M | 101.0M |